Expert Tip From RxStrategies

img
img

TIP: The key to unlocking the full potential of your program starts with complete understanding of your data.


Read More »

“This Is Bananas”: Hospitals Irate About HRSA’s Snap Decision to End 340B Patient Eligibility Clarification

Hospital outpatient location
340B hospitals expressed shock at HRSA's decision to cease a policy that has let patients receive 340B drugs at offsite outpatient locations that are sill going through the 340B registration process.

Editor’s note: New information from HRSA and Apexus obtained as we were going to press appears at the end of this article.

Hospital representatives said they were floored to learn yesterday that a June 2020 federal 340B patient eligibility policy

Read More »

U.S. House Panel Not Expected to Markup 340B Legislation at Hearing Next Week

House Energy & Commerce Committee
The U.S. House Energy & Commerce health subcommittee is not expected to move any 340B legislation in May, sources say.

A U.S. House Energy & Commerce subcommittee plans next week to markup bills on transparency and competition in health care and send them to the full committee for votes before Memorial Day. Although its Republican vice chair’s draft 340B bill

Read More »

Lifestar, Chartwell Announce Refunds for Q4 2022 340B Overcharges

340B refund notices
HRSA recently posted notices on its website of refunds for 340B overcharges from two generic drug manufacturers.

Generic drug manufacturers Lifestar Pharma and Chartwell Pharmaceuticals may owe refunds to 340B covered entities for overcharges on drugs purchased from the companies in the fourth quarter of 2022, according to recent notices posted on the U.S. Health Resources and

Read More »

340B INDUSTRY LEADER SPOTLIGHT

Jamila (“Jam”) Seibel, Director, Alinea Group

Jam Seibel

Q: Where did you grow up?

Clifton Park, New York, a small suburb upstate, between Albany and Saratoga Springs, NY.

Q: Where did you go to college?

I entered the 6-year Doctor of Pharmacy program at Massachusetts College of Pharmacy and Health Sciences directly after high school. After completing my Pharm.D., I completed a PGY1 pharmacy residency

Read More »

Exclusive

HRSA Says COVID Flexibility About Dispensing 340B Drugs in Unregistered Hospital Offsite Locations Will End Thursday

COVID-19 flexibility
HRSA has reversed course and will end a 340B COVID-19 flexibility that it previously said was permanent that lets hospitals under certain conditions start using 340B drugs at offsite outpatient locations sooner than HRSA would normally allow.

The U.S. Health Resources and Services Administration said late Friday that when the COVID-19 public health emergency ends on Thursday, so too will a nearly three-year-old policy clarification that lets hospitals under certain conditions dispense 340B drugs at offsite outpatient

Read More »

In Shift, 340B Health and AHA Now Say They Back Congressional Action on 340B Contract Pharmacy

Doris Matsui
340B Health and the AHA say they support 340B contract pharmacy legislation that Rep. Doris Matsui (D-Calif.) is working on.

Hospital group 340B Health and the American Hospital Association both have decided to support federal legislation to prohibit drug manufacturer restrictions on 340B covered entities’ use of contract pharmacies. A senior AHA official was quoted in a news article just

Read More »

340B Sales Growth Rate Softened for Second Straight Year, Data Show

IQVIA
Prescription drug sales at 340B prices softened for the second consecutive year compared with sales growth from 2019 to 2020, data in a new IQVIA white paper show.

Prescription drug sales at 340B prices grew 12.2% year-on-year from 2021 to 2022, drug industry consulting and research firm IQVIA says in a new white paper. That is down 3.7 percentage points compared with 340B sales growth from 2020

Read More »

340B Health Centers Urge N.Y. State Trial Court to Block Medicaid Pharmacy Transfer

New York
Two New York health centers are seeking a preliminary injunction against the state's shift of Medicaid managed care pharmacy benefits to Medicaid fee for service.

Two New York health centers have filed a new request with a state trial court to stop a recently launched state pharmacy benefit transfer, which the plaintiffs argue will cost providers millions in annual 340B revenue.

The April 26

Read More »

Ex-GOP Congressman Burton Slams Current GOP Rep. Rosendale’s 340B Bill

Dan Burton
Retired U.S. Rep. Dan Burton (R-Ind.) lauded the 340B program and criticized a current GOP congressman's 340B bill in a newspaper op-ed this week.

Former Republican Congressman Dan Burton (Ind.) called the 340B program “a win for all parties involved” in a Kokomo, Indiana newspaper op-ed this week and said a current House Republican’s 340B bill could deny vulnerable Hoosiers access to care.

Rep.

Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live